CRISPR Gene Activation Shows Early Promise but Modest Effects in Lab Models of Parkinson’s Disease
Researchers used a vector-free CRISPR activation system to boost dopamine biosynthesis genes in cellular models of Parkinsonian neurotoxicity, finding modest ...
